Saxenda in AI answers

Saxenda is an injectable prescription medicine (liraglutide) for adults with obesity or overweight with weight-related medical problems, and for some teens aged 12-17 with obesity, to help them lose weight and keep it off when used with a reduced-calorie diet and increased physical activity. It carries safety considerations, including a potential risk of thyroid tumors, and is not recommended for people with a history of certain thyroid cancers or MEN 2; it is not known to be safe for children under 12. Novo Nordisk has announced it will discontinue Saxenda, with last shipments to wholesalers in late January 2027, and provides customer care and support for coverage and alternatives.